GSK Plc ADR
GSK Plc ADR (GSK) Options Open Interest
GSK options open interest is 53,191 contracts. The 2-week average daily volume is 1,884 contracts across the chain.
Read more
Monitoring GSK open interest helps you see where real money is positioned on GSK Plc ADR's options and which strikes are attracting the most commitment from traders. GSK Plc ADR's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor GSK options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising GSK options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect GSK Plc ADR to settle.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections.
It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where GSK open interest is concentrated. Our scanner maps GSK Plc ADR's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade GSK Plc ADR's options open interest as the signal it is, not as an afterthought.
| 53.00 | — | 2.15 | 2.15 | 135% | +0.3793 | 384 |
| 52.00 | — | 0.15 | 0.15 | 35% | +0.1315 | 214 |
| 54.00 | — | 0.05 | 0.05 | 40% | +0.0467 | 164 |
| 51.00 | 0.05 | 0.25 | 0.15 | 26% | +0.1667 | 128 |
| 59.00 | — | 2.15 | 2.15 | 198% | +0.2952 | 28 |
| 49.00 | 0.25 | 0.70 | 0.48 | 23% | -0.4214 | 121 |
| 45.00 | — | 0.35 | 0.35 | 67% | -0.1467 | 72 |
| 47.50 | — | 0.25 | 0.25 | 33% | -0.1994 | 72 |
| 48.00 | 0.15 | 0.25 | 0.20 | 25% | -0.2111 | 61 |
| 46.00 | — | 1.20 | 1.20 | 97% | -0.2785 | 52 |
As of September 28, 2026
Follow the money
Track GSK open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→